Immunai CTO and Co-Founder Luis Voloch on Using Deep Learning to Develop New Drugs - Ep. 176

Immunai CTO and Co-Founder Luis Voloch on Usi...

Up next

Inside Instacart's AI-Powered Smart Shopping Cart | NVIDIA AI Podcast Ep. 302

Instacart has 1.6 billion lifetime grocery orders—and is now using that data flywheel to digitize the physical store itself. In this episode, David McIntosh, Chief Connected Stores Officer at Instacart, explains how the Caper Cart—powered by an NVIDIA Jetson™ board and a sensor f ...  Show more

How Mistral Is Building Frontier AI for the Enterprise | NVIDIA AI Podcast Ep. 301

Open-weight models are closing the gap with proprietary AI — and Timothée Lacroix, cofounder and CTO of Mistral, has been betting on that since day one. In this episode, he explains why open weights accelerate enterprise adoption, how Mistral is bringing model customization into ...  Show more

Recommended Episodes

HIBT Lab! Immunai: Noam Solomon
How I Built This with Guy Raz

According to the CDC, 6 in 10 adults in the U.S. have a chronic disease like cancer or diabetes. Meanwhile, the process for discovering new drug treatments is critically expensive and inefficient. About 90% of drug candidates fail to gain FDA approval; the average cost to develop ...  Show more

Immune 4: Putting the immunotherapy CAR T before the cancer
Immune

The immu-knowledge-ists deconstruct the holy grail of oncologists, cancer immunotherapy, and the exciting development of CAR T cells and how they work.

Hosts: Vincent Racaniello

  Show more

Immunotherapy: Transforming How Cancers Are Treated
Cancer Straight Talk

In this episode, Dr. Diane Reidy-Lagunes talks to medical oncologist and scientist Dr. Jedd Wolchok and cancer survivor Grace Dunn. Together, they help decode the emerging new defense against cancer: immunology. For more information or to ask a question, please visit MSKCC.org/po ...  Show more

Switzerland, AI and Liquid Biopsies
Faces of Digital Health

AI and predictive modeling to understand an individual’s immune system function and predict treatment response are still in very early stages. We dream about precision medicine and getting every answer we can for ourselves when we get sick. However, if we look at genomics, only a ...  Show more